Targeting the palm: a leap forward toward treatment of keratin disorders.
暂无分享,去创建一个
T. Magin | M. Hatzfeld | W. Roth | W. Roth
[1] C. Contag,et al. Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. , 2012, The Journal of investigative dermatology.
[2] Chang-Hun Lee,et al. Defining keratin protein function in skin epithelia: Epidermolysis Bullosa Simplex and its aftermath , 2011, The Journal of investigative dermatology.
[3] S. Bracke,et al. Lipid-mediated gene delivery to the skin. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] Jonathan E. Moore,et al. Development of Allele-Specific Therapeutic siRNA in Meesmann Epithelial Corneal Dystrophy , 2011, PloS one.
[5] Beverly L. Davidson,et al. Current prospects for RNA interference-based therapies , 2011, Nature Reviews Genetics.
[6] R. Hickerson,et al. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] E. Lane,et al. The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases , 2008, Human mutation.
[8] M. Omary,et al. A mutation of keratin 18 within the coil 1A consensus motif causes widespread keratin aggregation but cell type-restricted lethality in mice. , 2007, Experimental cell research.
[9] D. Roop,et al. An Inducible Mouse Model for Epidermolysis Bullosa Simplex , 2001, The Journal of cell biology.
[10] E. Fuchs,et al. Functional Differences between Keratins of Stratified and Simple Epithelia , 1998, The Journal of cell biology.
[11] K. Zatloukal,et al. Lessons from Keratin 18 Knockout Mice: Formation of Novel Keratin Filaments, Secondary Loss of Keratin 7 and Accumulation of Liver-specific Keratin 8-Positive Aggregates , 1998, The Journal of cell biology.